胶质母细胞瘤术后热疗同步放化疗初步生存分析

目的:初步探讨已行肿瘤切除术的胶质母细胞瘤(GBM)患者热疗同步放化疗是否延长患者生存期。方法:回顾分析2016—2019年间郑州大学第一附属医院61例GBM术后患者，根据治疗方式不同分为对照组34例，观察组27例。对照组采用三维放疗60 Gy联合替莫唑胺化疗，观察组在对照组基础上同步40~41℃，15~20次热疗。...

Preliminary survival analysis of postoperative simultaneous radiochemotherapy with hyperthermia in glioblastoma patients

Objective To initially investigate whether simultaneous radiochemotherapy with hyperthermia can prolong the survival of glioblastoma (GBM) patients. Methods Clinical data of 61 GBM patients undergoing surgery in our hospital from September 2016 to June 2019 were retrospectively analyzed. According to different treatment methods, all patients were divided into the control group (n=34) and observation group (n=27). In the control group, three-dimensional radiotherapy with a dose of 60Gy combined with temoazolamine chemotherapy was delivered. In the observation group, simultaneous radiochemotherapy with 15-20 cycles of hyperthermia at 40-41℃ was supplemented. The survival time was calculated by Kaplan-Meier method, and the survival time was compared with log-rank test between two groups. Results The median progression-free survival in the observation group was significantly longer than that in the control group (14.33 months vs.9.94 months, P<0.05). The median overall survival in the observation group was also remarkably higher than that in the control group (18 months vs. 14 months, P<0.05). Conclusions Simultaneous radiochemotherapy with hyperthermia is innovatively applied to treat GBM after surgical resection. Preliminary findings demonstrate that compared with chemoradiotherapy, simultaneous radiochemotherapy with hyperthermia can prolong the survival time of GBM patients.